This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== Adrenaline (Treatment) ====== ===== - Overview ===== Adrenaline is an endogenous catecholamine, and is used pharmacologically as a sympathomimetic agent. It acts on the β and α adrenoreceptors with dose-dependent selectivity. It is used to treat anaphylaxis, symptomatic bradycardia (e.g. in β-blocker toxicity), and cardiac arrest. ===== - Toxicologic Indications & Dosing ===== ==== - Anaphylaxis ==== * Also see: [[anaphylaxis]]. * **Adult:** * 💊 **Adrenaline 0.5 mg IM** (0.5 mL of 1:1,000), q5min PRN. * **Child:** * 💊👶 **Adrenaline 10 micrograms/kg IM** (0.01 mL/kg of 1:1,000), q5min PRN. Min dose 0.1 mL, max dose 0.5 mL. * IV adrenaline may be given only by experienced specialists in an appropriate setting, as the dose requirements are different. ==== - Bradycardia ==== * Also see: [[:beta_blocker_toxicity|Beta Blocker Toxicity]]. * **Adult:** * 💊 **Adrenaline 5-20 microgram IV**, q3min PRN. * 💊 **Adrenaline 2-10 microgram/min IV infusion**, titrate to response. * **Child:** * 💊👶 **Adrenaline 10 microgram/kg IV** (0.1 mL/kg of 1:10,000), q3min PRN. * 💊👶 **Adrenaline 0.1-1.5 microgram/kg/min IV infusion**, titrate to response. ==== - Cardiac Arrest ==== * Also see: [[cardiac arrest]]. * **Adult:** 💊 **Adrenaline 1 mg IV**, every 2 cycles. * **Child:** 💊👶 **Adrenaline 10 microgram/kg IV**, every 2 cycles. ===== - Cautions & Contraindications ===== There are no absolute contraindications to the use of adrenaline in a life-threatening situation. * Overtreatment may result in hypertension and tachyarrhythmias. * ↑ serum lactate. * Myocardial ischemia. ===== - Special Populations ===== **Pregnancy rating:** A (AU/NZ) **Lactation:** Excreted in breast milk, but potential effects on breastfed infant is unknown. ===== - Adverse Effects ===== * **CVS:** hypertension, tachyarrhythmias, myocardial ischemia. * **CNS:** anxiety, tremor. * **Skin:** tissue necrosis if extravasates. * **Metabolic:** hyperglycemia, hyperlactatemia. ===== - Pharmacology ===== ==== - Pharmacodynamics ==== **Mechanism of action:** Dose-dependent adrenoceptor activity, with β-agonist effects predominate at low doses, and added α-agonist effects at higher doses. ==== - Pharmacokinetics ==== **Absorption:** * Oral bioavailability: 0%. **Distribution:** * Vd: 0.1-0.2 L/kg. * Lipid solubility: * Does not cross BBB * Crosses placenta * Excreted in breast milk * Protein binding: 50% **Metabolism:** Rapidly metabolized by COMT and MAO into metanephrine and 3,4-dihydroxymandelic acid, then ultimately into vanillylmandelic acid. **Excretion:** * Elimination t½: 2-3 mins. * Renal clearance: Renally excreted, mostly as inactive metabolites. ==== - Pharmaceutics ==== **Formulation:** * Ampoules containing 1000 microgram/1 mL or 1000 microgram/10 mL. * Autoinjector with varying doses (commonly 0.15 mg, 0.3 mg, 0.5 mg). Various brands exist, e.g. EpiPen, Emerade, Auvi-Q. ===== - References ===== Useful general references: ~~REFNOTES~~ CKG Edit